Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−140KRW
−2.51 BKRW
370.54 BKRW
12.29 M
About ILYANG PHARM
Sector
CEO
Dong-Yeon Kim
Headquarters
Yongin-si
Website
Employees (FY)
641
Founded
1946
ISIN
KR7007570005
FIGI
BBG000BDMPJ8
Il-Yang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. It operates through the following business divisions: Specialty Meidicine, Over-the-counter Medicine, Export, and Others. Its products include ethical and over-the counter drugs under the brand names of NolTec, Supect, and Wonbi-D. The company was founded on July 1, 1946 and is headquartered in Yongin-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 007570 is 13710 KRW — it has increased by 0.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ILYANG PHARM stocks are traded under the ticker 007570.
ILYANG PHARM is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
007570 stock is 1.17% volatile and has beta coefficient of 0.82. Check out the list of the most volatile stocks — is ILYANG PHARM there?
ILYANG PHARM revenue for the last quarter amounts to 89.80 B KRW despite the estimated figure of 84.60 B KRW. In the next quarter revenue is expected to reach 84.00 B KRW.
Yes, you can track ILYANG PHARM financials in yearly and quarterly reports right on TradingView.
007570 stock has fallen by 1.01% compared to the previous week, the month change is a 7.99% fall, over the last year ILYANG PHARM has showed a 19.40% decrease.
007570 net income for the last quarter is −7.38 B KRW, while the quarter before that showed 4.83 B KRW of net income which accounts for −252.71% change. Track more ILYANG PHARM financial stats to get the full picture.
Today ILYANG PHARM has the market capitalization of 245.85 B, it has increased by 0.22% over the last week.
Yes, 007570 dividends are paid annually. The last dividend per share was 150.00 KRW. As of today, Dividend Yield (TTM)% is 1.10%. Tracking ILYANG PHARM dividends might help you take more informed decisions.
Like other stocks, 007570 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILYANG PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 641.00 employees. See our rating of the largest employees — is ILYANG PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILYANG PHARM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILYANG PHARM stock shows the sell signal. See more of ILYANG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILYANG PHARM EBITDA is 33.19 B KRW, and current EBITDA margin is 8.96%. See more stats in ILYANG PHARM financial statements.